Navigation Links
Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix
Date:5/11/2011

FORT WORTH, Texas, May 11, 2011 /PRNewswire/ -- Healthpoint Biotherapeutics today announced the introduction of OASIS® Ultra Tri-Layer Matrix, a natural extracellular matrix (ECM) material derived from three layers of porcine small intestinal submucosa (SIS). The three-layer construct of ECM was designed to incorporate increased structure into difficult-to-heal and chronic wounds.

"We are pleased to introduce OASIS® Ultra as an extension of our SIS product offerings," said Travis Baugh, President and Chief Operating Officer of Healthpoint Biotherapeutics. "The three-layer design provides healthcare professionals with an important therapeutic option for temporary ECM replacement in complex wounds where increased strength and thickness is called for as part of the treatment protocol."

SIS, the base technology for OASIS® Ultra, is among the most widely studied and published biomaterials, featured in more than 832 scientific publications.

OASIS® Ultra is indicated for the management of wounds including surgical, partial- and full-thickness, traumatic (including second degree burns), venous ulcers, chronic vascular ulcers, diabetic and pressure ulcers, and draining wounds.  The product should not be used in patients with known sensitivity to porcine material and is not indicated for use in third-degree burns.

About Healthpoint Biotherapeutics

Healthpoint Biotherapeutics is a biopharmaceutical company focused on the development and commercialization of novel, cost-effective solutions for tissue repair and healing. The company's diversified research and development strategy is presently centered around therapeutic enzymes, biologics and next-generation cell- and cell-matrix based therapies for the prevention and treatment of acute, chronic and burn-related wounds. Currently marketed products include Collagenase SANTYL® Ointment, OASIS® Wound Matrix and OASIS® Ultra Tri-Layer Matrix. Healthpoint Biotherapeutics is also committed to advancing the care and treatment of wounds through support of industry-leading continuing education from The Wound Institute®. To learn more about this comprehensive and award winning educational resource, please visit TheWoundInstitute.com.  Healthpoint Biotherapeutics is a DFB Pharmaceuticals, Inc., affiliate company, and is based in Fort Worth, Texas. For more information, visit the company website at www.Healthpoint.com.

HEALTHPOINT, SANTYL, THE WOUND INSTITUTE and THEWOUNDINSTITUTE.COM are registered trademarks of Healthpoint, Ltd.

OASIS is a registered trademark of Cook Biotech, Inc.


'/>"/>
SOURCE Healthpoint Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Healthpoint Launches New Corporate Identity
2. Healthpoint to Present at 29th Annual J.P. Morgan Healthcare Conference
3. Healthpoint Launches Collagenase SANTYL(R) Ointment in Canada
4. HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
5. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
6. Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing
7. Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff
8. Oxford BioTherapeutics Licenses BioWas POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer
9. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
10. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
11. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 22, 2017 The intersection ... and more prevalent today resulting in identifying and ... as well as other botanicals for discovering the ... marijuana therapies and their applications. Cannabis companies are ... designed to bring the new therapies to the ...
(Date:2/22/2017)... HAMBURG, Germany , February 22, 2017 ... Hamburg, Germany and The Indian Institute of ... a collaboration to support the first Indian national cancer data base ... ... with an initial three-year term. The collaboration will include collection of ...
(Date:2/21/2017)... , Feb. 21, 2017 Mass ... report: http://www.reportlinker.com/p04711309-summary/view-report.html This report ... well as future prospects of the market globally. ... intermediaries engaged in the manufacture and commercialization of ... as new entrants planning to enter this market. ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... ANGLESTRONG , ... Angle, is now available on the App Store and Google Play ... apps for the addiction and recovery industry, partnered with Angle to build ANGLESTRONG. The ...
(Date:2/22/2017)... ... 2017 , ... Michael J. Hennessy Associates, Inc. (MJH Associates), ... professionals and other key stakeholders with an array of valuable resources, Healthcare Analytics ... announced Michael J. Hennessy, Jr., president of MJH Associates. , In making ...
(Date:2/22/2017)... Troy, NY (PRWEB) , ... February 22, 2017 , ... ... effort — especially for hospitals and health systems. Smith & Jones’ delves into this ... In this episode, President of Smith & Jones David Vener meets up with social ...
(Date:2/22/2017)... ... February 22, 2017 , ... Alto-Shaam ... the Vector™ Series Multi-Cook Oven offers up to four ovens in one. Control ... Air Technology™ for unmatched evenness in cooking. Alto-Shaam has partnered with Appliance Innovation ...
(Date:2/21/2017)... ... February 21, 2017 , ... Tripp Lite, a world-leading ... extension cords that meet the most current standards. , The adoption by the ... National Fire Protection Association (NFPA) 101 – Life Safety Code (LSC) and NFPA ...
Breaking Medicine News(10 mins):